Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2005, Vol. 106, No. 1, pp. 362-367.
Prepublished online as a Blood First Edition Paper on March 17, 2005; DOI 10.1182/blood-2005-01-0160.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-01-0160v1
106/1/362    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macciò, A.
Right arrow Articles by Mantovani, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macciò, A.
Right arrow Articles by Mantovani, G.
Related Collections
Right arrow Neoplasia
Right arrow Red Cells
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RED CELLS

Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia

Antonio Macciò, Clelia Madeddu, Daniela Massa, Maria C. Mudu, Maria R. Lusso, Giulia Gramignano, Roberto Serpe, Gian Benedetto Melis, and Giovanni Mantovani

From the Department of Obstetrics and Gynecology, Sirai Hospital, Carbonia, Italy; the Department of Medical Oncology, University of Cagliari, Cagliari, Italy; and the Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy.

Anemia occurs in more than 30% of patients with epithelial ovarian cancer before any surgery. High levels of proinflammatory cytokines and increased oxidative stress may contribute to the development of cancer-related anemia. We assessed a population of previously untreated patients with advanced epithelial ovarian cancer to evaluate whether there was a correlation between hemoglobin (Hb) and parameters of inflammation and oxidative stress, stage of disease, and performance status (PS). In 91 patients with epithelial ovarian cancer and 95 healthy women matched for age, weight, and height, levels of Hb, C-reactive protein (CRP), fibrinogen (Fbg), proinflammatory cytokines, leptin, reactive oxygen species (ROS), and antioxidant enzymes were assessed at diagnosis before treatment. The correlations between Hb, parameters of inflammation and oxidative stress, stage, and PS were evaluated. Hb levels were lower in patients with advanced epithelial ovarian cancer than in control subjects and inversely related to stage and PS. Hb negatively correlated with CRP, Fbg, interleukin 1{beta} (IL-1{beta}), IL-6, tumor necrosis factor {alpha} (TNF{alpha}), and ROS, and positively correlated with leptin and glutathione peroxidase (GPx). Multivariate regression analysis showed that stage and IL-6 were independent factors determining Hb values. This evidence suggests that anemia in epithelial ovarian cancer is common and its presence is related to stage of disease and markers of inflammation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
J. L. Spivak, P. Gascon, and H. Ludwig
Anemia Management in Oncology and Hematology
Oncologist, September 1, 2009; 14(suppl_1): 43 - 56.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G. Mantovani
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma
Ann. Onc., July 1, 2008; 19(7): 1355 - 1355.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
K. Heikkila, S. Ebrahim, and D. A Lawlor
A systematic review of the association between circulating concentrations of C reactive protein and cancer
J Epidemiol Community Health, September 1, 2007; 61(9): 824 - 833.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
X. Zhang, D. P. Sejas, Y. Qiu, D. A. Williams, and Q. Pang
Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence
J. Cell Sci., May 1, 2007; 120(9): 1572 - 1583.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. N. Roy, H. H. Mak, I. Akpan, G. Losyev, D. Zurakowski, and N. C. Andrews
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation
Blood, May 1, 2007; 109(9): 4038 - 4044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams, and Q. Pang
Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice
J. Immunol., April 15, 2007; 178(8): 5277 - 5287.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020